Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma

Por Huang, Chun-Ming, Huang, Ming-Yii, Tang, Jen-Yang, Chen, Shinn-Cherng, Wang, Liang-Yen, Lin, Zu-Yau, Huang, Chih-Jen
Publicado no World J Surg Oncol (2015)

Clinical Evaluation of the Automated COBAS AMPLICOR HCV MONITOR Test Version 2.0 for Quantifying Serum Hepatitis C Virus RNA and Comparison to the Quantiplex HCV Version 2.0 Test

Por Yu, Ming-Lung, Chuang, Wan-Long, Dai, Chia-Yen, Chen, Shinn-Cherng, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Chang, Wen-Yu
Publicado em 2000

The impact of an additional extra-hepatic primary malignancy on the outcomes of patients with hepatocellular carcinoma

Por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Ming-Yen, Lin, Zu-Yau, Huang, Jee-Fu, Dai, Chia-Yen, Yu, Ming-Lung, Chen, Shinn-Cherng, Chuang, Wan-Long
Publicado no PLoS One (2017)

High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study

Por Yu, Ming-Lung, Dai, Chia-Yen, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Tsai, Jung-Fa, Chang, Wen-Yu, Chuang, Wan-Long
Publicado em 2005

Comparison of adverse effects related to pegylated interferon-based therapy for patients with chronic hepatitis B and chronic hepatitis C in Taiwan

Por Yang, Jeng-Fu, Kao, Yi-Hui, Dai, Chia-Yen, Huang, Jee-Fu, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Hsieh, Ming-Yuh, Wang, Liang-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado em 2010

Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients

Por Yeh, Ming-Lun, Peng, Cheng-Yuan, Dai, Chia-Yen, Lai, Hsueh-Chou, Huang, Chung-Feng, Hsieh, Ming-Yen, Huang, Jee-Fu, Chen, Shinn-Cherng, Lin, Zu-Yau, Yu, Ming-Lung, Chuang, Wan-Long
Publicado no PLoS One (2015)

Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin

Por Dai, Chia-Yen, Chuang, Wan-Long, Chang, Wen-Yu, Chen, Shinn-Cherng, Lee, Li-Po, Hsieh, Ming-Yen, Hou, Nei-Jen, Lin, Zu-Yau, Hsieh, Ming-Yuh, Wang, Liang-Yen, Yu, Ming-Lung
Publicado no World J Gastroenterol (2005)

The effect of antiviral therapy on serum lipid profiles in chronic hepatitis C

Por Batsaikhan, Batbold, Huang, Ching-I, Yeh, Ming-Lun, Huang, Chung-Feng, Hou, Nei-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Yu, Ming-Lung, Chuang, Wan-Long, Lee, Jin-Ching, Dai, Chia-Yen
Publicado no Oncotarget (2018)

A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C

Por Yu, Ming‐Lung, Dai, Chia‐Yen, Huang, Jee‐Fu, Hou, Nai‐Jen, Lee, Li‐Po, Hsieh, Ming‐Yen, Chiu, Chang‐Fu, Lin, Zu‐Yau, Chen, Shinn‐Cherng, Hsieh, Ming‐Yuh, Wang, Liang‐Yen, Chang, Wen‐Yu
Publicado em 2007

Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy

Por Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Cing-Yi, Tsai, Pei-Chien, Ko, Yu-Min, Chen, Kuan-Yu, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Chuang, Wan-Long, Huang, Jee-Fu, Yu, Ming-Lung
Publicado no Medicine (Baltimore) (2016)

Revisiting the Stopping Rule for Hepatitis C Genotype 1 Patients Treated with Peginterferon Plus Ribavirin

Por Yu, Ming-Lung, Liu, Chen-Hua, Huang, Chung-Feng, Tseng, Tai-Chung, Huang, Jee-Fu, Dai, Chia-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Kao, Jia-Horng
Publicado em 2012

PNPLA3 genetic variants determine hepatic steatosis in non-obese chronic hepatitis C patients

Por Huang, Chung-Feng, Chen, Jyh-Jou, Yeh, Ming-Lun, Huang, Ching-I, Hsieh, Ming-Yen, Yang, Hua-Ling, Dai, Chia-Yen, Huang, Jee-Fu, Lin, Zu-Yau, Chen, Shinn-Cherng, Chuang, Wan-Long, Chen, Yao-Li, Yu, Ming-Lung
Publicado no Sci Rep (2015)

Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

Por Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Kuo, Po-Lin, Kuo, Hsing-Tao, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Publicado no Oncotarget (2018)

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

Por Huang, Chung-Feng, Dai, Chia-Yen, Yeh, Ming-Lun, Huang, Jee-Fu, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Wang, Liang-Yen, Juo, Suh-Hang Hank, Chuang, Wan-Long, Lin, Yi-Ching, Yu, Ming-Lung
Publicado em 2013

HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma

Por Lin, Shi-Ming, Lu, Sheng-Nan, Chen, Ping-Tsung, Jeng, Long-Bin, Chen, Shinn-Cherng, Hu, Chi-Tan, Yang, Sien-Sing, Le Berre, Marie-Aude, Liu, Xuan, Mitchell, David Y., Prins, Klaas, Grevel, Joachim, Peña, Carol A. E., Meinhardt, Gerold
Publicado no Hepatol Int (2016)

Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes

Por Huang, Ching-I, Huang, Chung-Feng, Yeh, Ming-Lun, Lin, Yi-Hung, Liang, Po-Cheng, Liu, Shang-Yin Vanson, Hsieh, Meng-Hsuan, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Chuang, Wan-Long, Dai, Chia-Yen, Yu, Ming-Lung
Publicado no Medicine (Baltimore) (2018)

Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study

Por Yeh, Ming-Lun, Hsieh, Ming-Yen, Huang, Ching-I., Huang, Chung-Feng, Hsieh, Meng-Hsuan, Liang, Po-Cheng, Lin, Yi-Hung, Hou, Nai-Jen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Publicado no Medicine (Baltimore) (2015)

Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment

Por Huang, Chung-Feng, Huang, Cing-Yi, Yeh, Ming-Lun, Wang, Shu-Chi, Chen, Kuan-Yu, Ko, Yu-Min, Lin, Ching-Chih, Tsai, Yi-Shan, Tsai, Pei-Chien, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado no EBioMedicine (2016)

Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C

Por Huang, Chung-Feng, Huang, Ching-I, Yeh, Ming-Lun, Wang, Shu-Chi, Chen, Kuan-Yu, Ko, Yu-Min, Lin, Ching-Chih, Tsai, Yi-Shan, Tsai, Pei-Chien, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado no Oncotarget (2017)

Corrigendum to “Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral...

Por Huang, Chung-Feng, Huang, Ching-I, Yeh, Ming-Lun, Wang, Shu-Chi, Chen, Kuan-Yu, Ko, Yu-Min, Lin, Ching-Chih, Tsai, Yi-Shan, Tsai, Pei-Chien, Lin, Zu-Yau, Chen, Shinn-Cherng, Dai, Chia-Yen, Huang, Jee-Fu, Chuang, Wan-Long, Yu, Ming-Lung
Publicado no EBioMedicine (2017)